Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study

OBJECTIVE: To compare the efficacy and safety of an initial triple therapy using metformin, a dipeptidyl peptidase-4 (DPP4) inhibitor, and thiazolidinedione with a stepwise approach using sulfonylurea and metformin in new-onset, drug-naïve patients with type 2 diabetes. RESEARCH DESIGN AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Soo, Ku, Eu Jeong, Lee, Seo Young, Lee, Ji Hyun, Lee, Jie-Eun, Kim, Kyoung Min, Davies, Melanie J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical Care/Education/Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039575/
https://www.ncbi.nlm.nih.gov/pubmed/31958303
http://dx.doi.org/10.1136/bmjdrc-2019-000807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039575/
https://www.ncbi.nlm.nih.gov/pubmed/31958303
http://dx.doi.org/10.1136/bmjdrc-2019-000807

Ejemplares similares